Olestra and the FDA.
Blackburn
H
H
D016265:Conflict of Interest; D004042:Dietary Fats, Unsaturated / Q000009:adverse effects; D004813:Epidemiology; D005069:Evaluation Studies as Topic; D005227:Fatty Acids / Q000009:adverse effects / Q000592:standards*; D005503:Food Additives / Q000009:adverse effects / Q000592:standards*; D006801:Humans; D013395:Sucrose / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000592:standards; D014481:United States; D014486:United States Food and Drug Administration / Q000458:organization & administration / Q000592:standards
D004042:Dietary Fats, Unsaturated; D005227:Fatty Acids; D005503:Food Additives; D013395:Sucrose; C013692:sucrose polyester